Explain the clinical manifestations, complications, diagnostic studies, and collaborative care of the patient with ACS, CAD, and ADHF.
Evaluate commonly used drug therapy in treating patients with ACS, CAD, and ADHF.
Prioritize key components to include in client education and nursing care of patients recovering from ACS and coronary revascularization procedures.
Leading cause of death in the world.
Pt usually comes in due to crisis (ex. MI, hypertension)
CVD includes several disorders of the heart and blood vessels.
Coronary Artery Disease (CAD): asymptomatic or chronic stable angina (chest pain).
Acute Coronary Syndrome (ACS): unstable angina (UA) or myocardial infarction (MI).
Perfusion depends on cardiac output (CO).
A type of blood vessel disorder.
Elevations in blood pressure because of plaque building up in arteries
C-reactive protein (CRP) may be increased.
Inflammatory marker
Atherosclerosis: begins as soft deposits of fat that harden with age.
CRP also an inflammatory marker
Lipid deposits within the innermost layer of the arterial wall (intima).
Endothelial injury and inflammation affect the development of atherosclerosis.
Damage to the endothelial lining due to: tobacco use, hyperlipidemia, hypertension, toxins, diabetes, inflammation, and infection.
Due to high lipoprotein and homocysteine levels.
Damage the inner lining of blood vessels.
Promote plaque buildup.
Change clotting mechanism = clots more likely to occur.
Fatty Streak (Stage 1):
Lipid-filled smooth muscle cells.
Yellow tinge appears, appears by age 20.
Treatments that lower LDL cholesterol may slow this process.
Fibrous Plaque (Stage 2):
Progressive changes to endothelium.
Grayish/whitish appearance, appears by age 30 and increases with age.
Plaques can form on one side of the artery or in a circular fashion.
Complicated Lesion (Stage 3):
Continued inflammation can result in plaque instability, ulceration, and rupture.
Platelets accumulate = thrombus = ↑ GP Iib/IIIa receptors to bind fibrinogen = enlarging thrombus.
Most dangerous stage and can lead to ACS.
Arterial anastomoses or connections exist within the coronary circulation (creates new pathways)
More common in older population as they’ve had more time to develop. An MI is more deadly in younger populations as they’ve had don’t have collateral circulation.
Ex. Think of a freeway that’s backed up → people go to the streets.
Two Contributing Factors:
Angiogenesis: inherited predisposition to develop new blood vessels.
Presence of chronic ischemia (poor blood flow).
Collateral Circulation has a chance to develop if blockage occurs slowly over a long time.
Acute coronary occlusion = not enough time for collateral circulation to develop.
Non-Modifiable:
Age
Gender
Ethnicity
Family History
Genetics
Major Modifiable:
High serum lipids
Hypertension
Tobacco Use
Physical Inactivity
Obesity
Diabetes
Metabolic Syndrome
Contributing Modifiable:
Psychological state
Substance use
Identify High-Risk Persons.
Obesity
Family Hx
Diabetes
Poor socioeconomic status (unhealthy diet)
Sedentary lifestyle
Physical Activity.
At least 150 minutes of moderate intensity exercise every week.
30 mins of brisk walking per day??
Nutrition Therapy.
Increase 9:03***LISTEN TO LECTURE
Lipid-Lowering Drug Therapy.
Complete lipid profile every 5 years beginning age 20; Middle-aged adults every 1-2 years.
Antiplatelet Therapy.
↑ Lipoprotein Removal
Bile Acid Sequestrants
Proprotein Convertase Subtilisin/kexin 9 inhibitors
↓ Cholesterol Absorption
Ezetimibe (Zetia)
Restrict Lipoprotein Production
HMG-CoA reductase inhibitors (Statins)
Niacin (water-soluble B vitamin)
Fibric Acid Derivatives (Gemfibrozil)
ATP-citrate lyase Inhibitor (Bempedoic Acid)
Chest pain due to myocardial ischemia. Artery >70% stenosed or >50% in L main coronary artery.
Chronic Stable Angina: due to chronic CAD over a long period of time.
Provoked by physical exertion, stress, emotional upset, sexual activity, stimulants.
Pain usually lasts for only a few minutes and does not change with position or breathing.
Treatment: rest, calming down, sublingual nitroglycerin, drug therapy, ↓ O2 demand & ↑ O2 supply.
Unstable Angina: new-onset pain that may increase in frequency, duration, or severity.
Occurs at rest or with exertion and lasts more than 10 minutes.
Unpredictable.
Incomplete occupation of vessel
Rupture of unstable plaque = thrombus formation = MI
Silent Angina: ischemia with the absence of any symptoms.
Diabetes due to neuropathy affecting the nerves that innervate the cardiovascular system.
Women: fatigue, SOB, epigastric pain, anxiety, nausea.
Drug Therapy: Nitrates (every 5 mins), ACE inhibitors, ARBs, β-adrenergic blockers, Calcium Channel blockers, Lipid-lowering drugs.
Goal: ↓ O2 demand & ↑ O2 supply to heart and rest of body.
Nursing Care:
Pain relief (morphine helps with pulmonary congestion)
Immediate and appropriate treatment
Preservation of heart muscle if MI suspected
Oxygenate (perfuse the issue to prevent cell and muscle death)
Effective coping with illness-associated anxiety
Participation in a rehabilitation plan
Reduction of risk factors
Patient Education
Identify risk factors for CAD
Reduce modifiable risk factors
Precipitating factors for angina
Medications
Diet
Physical Exercise
Chest pain from ischemia is prolonged and not immediately reversible
Coronary artery disease
Chronic stable angina
Acute coronary syndrome
Unstable angina
Non-ST-segment-elevation MI
ST-segment-elevation MI (STEMI)
Unstable Angina (UA): chest pain at rest, new onset, worsening symptoms, unpredictable, usually lasts >10 mins
Chronic angina/CAD that can lead to myocardial infarction
Rupture of unstable plaque = thrombus formation
Incomplete occlusion of vessel
Myocardial Infarction: abrupt stoppage of blood flow through a coronary artery with thrombus d/t platelet aggregation
Will have ischemia
Pt will present with cold and clammy skin that has a gray-ish in appearance
Non-ST-elevation Myocardial Infarction (NSTEMI)
Incomplete occlusion of vessel
NOT emergent. Cardiac cath in 12-72 hrs. No thrombolytics.
ST-elevation Myocardial Infarction (STEMI)
Complete occlusion of vessel
Emergency - Door to balloon < 90 mins or Door to drug < 30 mins
Chest pain
Heavy, pressure, tight, burning, constricted, or crushing pain in the substernal or epigastric area. May radiate to neck, lower jaw, arms, or back.
Atypical: “discomfort”, weakness, nausea, indigestion, SOB, fatigue
Older adult: mental status change, SOB, pulmonary edema, dizziness, dysrhythmia
Sympathetic Nervous System Stimulation
↑ HR and BP initially, vasoconstriction of peripheral blood vessels, diaphoresis, clammy/ashen/cool to touch skin
Due to catecholamine release (epinephrine and norepinephrine release as compensation)***
Cardiovascular
↓ HR and BP d/t ↓ cardiac output = ↓ renal perfusion & urine output
LV dysfunction = Crackles, S3 and S4 heart sounds
RV dysfunction = JVD, hepatic engorgement, peripheral edema
Nausea and Vomiting
LISTEN TO LECTURE 20:17****
Fever
Cell death = inflammatory process
Within 24 hours leukocytes infiltrate the area, dead heart cells release enzymes, lipolysis, and glycogenolysis occurs
Necrotic muscle wall thins by day 4 d/t neutrophils and macrophages
New scar tissue forming, but still weak after 10-14 days
6 weeks after MI, scar tissue has replaced necrotic tissue → Considered healed at this point.
Ø Risk for life-threatening dysrhythmias = sudden cardiac death (SCD)
Ø Ventricular remodeling: myocardium hypertrophies and dilates → NOT GOOD.
The healthy heart tissue that remains has to compensate for the ischemic muscles.
Thick heart muscles cannot pump out blood effectively (hypertrophy) → HF
Dilated/thin heart muscles cannot pump to blood effectively → HF
Harder force of contraction (increased inotrope)
12 Lead ECG -NOT TESTED ON EACH LEAD
Each lead looks at heart at a different angle.
Provides information on which coronary artery is involved
ST depression and/or T wave inversion facing ischemia/infarction
Ischemic changes seen in UA or NSTEMI
STEMI
ST elevation in the leads facing the infarcted wall
ST segment elevation of 1mm or greater in 2 contiguous leads or 2mm or more in V2 and V3
Pathologic Q waves → tells us if there’s some type of damage to heart (ex. CMP, late HF)
If the patient does not seek immediate treatment
Deep Q wave or Q wave ≥ 1/3 of R wave height
Always compare to previous ECGs if possible!
Serum Cardiac Biomarkers:
UA: negative
NSTEMI: positive
Enzyme | Rises In | Peaks In | Remains Elevated For |
---|---|---|---|
CK-MB | |||
Normal range: 0 to 4-6% of total CK > 6% positive | 6 hrs | 18 hrs | 24 – 36 hours |
Cardiac Troponin I (Most Common) | |||
Negative: < 0.5 ng/mL Indeterminate: 0.5 – 2.3 ng/mL Positive: > 2.3 ng/mL | 4 - 6 hrs | 10 - 24 hours | 10 to 14 days |
Echocardiogram:
Hypokinesis: worsening myocardial contractility
Akinesis: absent myocardial contractility
Cardiac Catheterization: Gold standard test for increasing angina symptoms to identify and localize CAD and for MI
A catheter is inserted into the coronary arteries to do several tests
Visual blockages (diagnostic)
Open blockages (interventional)
Coronary Angiogram/Angiography (CTA):
Inject contrast dye to assess blood flow
Coronary Revascularization with Percutaneous Coronary Intervention (PCI)
Balloon Angioplasty/Intracoronary Stents:
Catheter with a deflated balloon tip is inserted into the blocked artery and then inflated. This pushes the plaque against the artery wall and a stent is usually placed. (Insertions site often the groin).
Bare metal stent (BMS)
Drug-eluting stent (DEC): coated with a drug to reduce overgrowth of the intimal lining
DAPT (aspirin + clopidogrel) used until intimal lining grows over stent. Minimum of 12 months. Aspirin continues forever with a stent.
Coronary Revascularization with Coronary Artery Bypass Graft Surgery (CABG)
Place one or more arterial/venous grafts to provide blood distal to blocked coronary artery. Uses saphenous vein, radial artery, or internal mammary artery.
Recommended if patient:
Does not respond well to medical management
Left main coronary artery or 3-vessel disease
Not candidates for PCI
Continue to have chest pain after PCI
Patients with DM, LV dysfunction, and/or CKD
Thrombolytic Therapy (tenecteplase, alteplase)
STEMI cases in agencies without cath lab
Limits infarction size by dissolving thrombus in the coronary artery
Administer within 3o mins
Inclusion criteria:
Chest pain < 12 hrs with 12-lead ECG findings of a STEMI
No absolute contraindications (active internal bleeding, hx of intracranial hemorrhage, etc.)
Drug Therapy
ACS = Antiplatelet, IV nitro, high-dose atorvastatin
Morphine, β-adrenergic blockers, ACE inhibitors/ARBs, antidysrhythmics, lipid-lowering, aldosterone antagonists, stool softeners
Nutrition Therapy
NPO until stable
Immediate goals: pain relief, quick and appropriate treatment, and preservation of heart muscle
Monitor vital signs, continuous ECG monitoring, 12-lead ECG, and draw serum cardiac biomarkers, bed rest/limit activity for 12-24 hours, administer nitro, morphine and oxygen therapy for chest pain, notify HCP of ANY changes (neuro status, etc), emotional support, patient education
Heparin—UA and NSTEMI
DAPT—NSTEMI and UA with stent
Aspirin—UA
Cardiac Catheterization—UA and NSTEMI
Medical management: PCI or CABG
Reperfusion therapy—STEMI
Emergent PCI
Thrombolytic therapy
Physical Activity: MET, limit isometric activities and continue isotonic activities, monitor HR
Cardiac Rehabilitation: restoration of a person to an optimal state of function in 6 areas.
Sexual Activity: resume when able to tolerate exercise ≥3-5 w/o chest pain or SOB
Pre-procedure: assess allergies, baseline assessment and vitals, NPO 6-12 hours, lab values, patient education
Cardiac Catheterization and PCI:
Post-procedure: assessment, monitor ECG, administer medications, monitor for complications, patient education
CABG:
Post-procedure: ICU (24-48 hours), hemodynamic monitoring, arterial line, chest tubes, ECG monitoring, ET tube to vent, urinary catheter, NG tube. Assess fluid status, replace blood/electrolytes, restore temperature, medications, sensory/motor function, pain management
Dysrhythmias: Ventricular tachycardia (VT), Ventricular fibrillation (VF), Heart Blocks
Heart Failure: Ventricle’s pumping action is reduced
Cardiogenic Shock: occurs when O_2 and nutrients to the tissues are inadequate
Goal: ↑ O2 delivery, ↓ O2 demand, and prevent complications
Papillary Muscle Dysfunction/Rupture: occurs if infarct near muscle that attaches to the mitral valve
New systolic murmur = indication of mitral valve regurgitation
Left Ventricular Aneurysm: infarcted heart muscle wall thins and bulges out during contraction
Ventricular Septal Wall Rupture/ Left Ventricular Free Wall Rupture: new loud systolic murmur
Pericarditis: inflammation of the visceral and/or parietal pericardium
Dressler Syndrome: pericarditis and fever 1-8 weeks after MI
Sudden Cardiac Death (SCD): abrupt, unexpected death resulting from a variety of cardiac issues without 1 hour of symptom onset
Most common cause is acute ventricular dysrhythmias (VT or VF) with or without MI = loss of CO and cerebral blood flow
Have a history of LV dysfunction (EF <35%), and/or structural heart disease (hypertrophic cardiomyopathy)
Clinical Manifestations: angina, palpitations, dizziness/lightheadedness
Use of an implantable cardioverter-defibrillator (ICD) to prevent event
Rapid CPR, defibrillation, and use of an automatic external defibrillator (AED) for witnessed arrest cases
Inability to provide sufficient blood to meet the oxygen demands of tissues and organs
Primarily caused by HTN and CAD
Left-sided HF
HFrEF
HFpEF
Right-sided HF
Biventricular
Preload
Used to assess systemic fluid status of patient
Indirect estimate of left atrial pressure (LAP)
Right Heart Preload:
CVP
Normal: 2 – 8 mmHg
Left Heart Preload:
PAWP (LAP)
Normal: 6 – 12 mmHg
Afterload
Right Ventricle Afterload is PVR.
Normal PVR: < 250 dynes-sec/cm^5
Left Ventricle Afterload is SVR.
Normal SVR: 800 – 1200 dynes- sec/cm^5
Increased Preload
Stroke Volume
Ventricular Work
Myocardial O_2 Needs
Decreased Preload
Stroke Volume
Ventricular Work
Myocardial O_2 Needs
Increased Afterload
Ventricular Work
Myocardial O_2 Needs
Stroke Volume
Decreased Afterload
Ventricular Work
Myocardial O_2 Needs
Stroke Volume
The force & velocity with which ventricular ejection occurs is reflected by the stroke work index (SWI)
SWI is the amount of work the ventricle performs with each heartbeat
Right Heart Contractility is RVSWI (Right Ventricular Stroke Work Index)
Normal 7 – 12 g/m^2/beat
Left Heart Contractility is LVSWI (Left Ventricular Stroke Work Index)
Normal 40 – 80 g/m^2$$/beat
I – No limitation of activity. Ordinary physical activity does not cause symptoms of HF
II – Slight limitation of physical activity. Comfortable at rest, but ordinary physical activity results in symptoms of HF
III – Marked limitation of physical activity. Comfortable at rest, but less than ordinary physical activity results in symptoms of HF.
IV – Inability to carry out any physical activity without discomfort. Symptoms may be present at rest.
Sudden increase in symptoms of HF with a decrease in functional status.
Pulmonary congestion
Volume overload
Interstital edema
Tachypnea
Pulmonary edema
No | Yes | |
---|---|---|
No | Dry-Warm | Wet-Warm |
PAWP normal CO normal | PAWP ↑ CO normal Dyspnea, edema, orthopnea | |
Signs and Symptoms: none | ||
Yes | Dry-Cold | Wet-Cold |
PAWP ↓ or normal CO ↓ | PAWP ↑ CO ↓ AMS, ↓ O2 sat, ↓UO, shock | |
Edema, hypotension, cool extremities |
History and Physical Assessment
Determine underlying cause
Chest X-Ray
12 lead ECG
Hemodynamic Monitoring
Echocardiogram
Endomyocardial biopsy in certain patients
Nuclear Studies
Cardiac Cath
Labwork
Serum chemistry
Cardiac Biomarkers
BNP / NT-proBNP
LFTs
Renal Function
Thyroid function
CBC
Lipid profile
UA
Positive Inotropes:
Dopamine
Dobutamine
PDE inhibitors:
Milrinone
Vasodilators:
Nitroprusside
Positioning – High Fowler’s
NIPPV or intubation
Circulatory Assist Devices – IABP, ECMO, LVAD
Continuous vital sign monitoring
Urine output
Perfusion assessment (I&Os)
Continuous ECG
Hemodynamic monitoring – BP, PAWP, CO
Cardioversion
Ultrafiltration